The Download: Montana’s new experimental drug rules
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Montana’s plan to become an experimental medical hub just pushed forward As of this week in Montana, biotech companies whose drugs have been through preliminary testing—sometimes in as few as 10…
Montana is set to become a hub for experimental medical treatments, thanks to a newly established review board that will evaluate drugs in their early stages of development. Biotech companies can pay $12,500 to apply to the review board, which could lead to the treatment being sold through experimental clinics. This unique right-to-try legislation allows anyone with informed consent and the ability to pay to access experimental drugs, a prospect that excites some in the longevity community but raises ethical concerns for others.
Kris DeVault, whose newborn son suffers from a rare condition, is eager to access a potentially life-changing drug that is still in the early stages of testing.
Written by urgent.news from MIT Technology Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Montana’s plan to become an experimental medical hub just pushed forward technologyreview.com
